Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:MDVL MedAvail (MDVL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About MedAvail Stock (NASDAQ:MDVL) 30 days 90 days 365 days Advanced Chart Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Get MedAvail alerts:Sign Up Key Stats Today's Range N/A50-Day Range$1.80▼$5.9552-Week Range N/AVolume245,100 shsAverage Volume261,432 shsMarket Capitalization$2.91 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.Read More… This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Receive MDVL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MedAvail and its competitors with MarketBeat's FREE daily newsletter. Email Address MDVL Stock News HeadlinesDelhi Bank Corp DWNXApril 18, 2024 | morningstar.comUS Stocks Mixed; Trimble Issues Weak OutlookFebruary 12, 2024 | msn.comI've got news for you… Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the weekNovember 25, 2024 | DTI (Ad)U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.33%February 12, 2024 | msn.comMedAvail Holdings Faces Nasdaq Delisting After BankruptcyFebruary 9, 2024 | msn.comWall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than ExpectedFebruary 8, 2024 | msn.comUS Futures Marginally Lower Ahead of Jobless Claims, Wholesale Trade DataFebruary 8, 2024 | msn.comU.S. shares higher at close of trade; Dow Jones Industrial Average up 0.37%February 6, 2024 | msn.comSee More Headlines MDVL Stock Analysis - Frequently Asked Questions How were MedAvail's earnings last quarter? MedAvail Holdings, Inc. (NASDAQ:MDVL) released its earnings results on Monday, November, 8th. The company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of ($0.32) by $0.02. The company earned $5.79 million during the quarter. MedAvail had a negative trailing twelve-month return on equity of 218.10% and a negative net margin of 192.97%. What other stocks do shareholders of MedAvail own? Based on aggregate information from My MarketBeat watchlists, some other companies that MedAvail investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Adobe (ADBE), Braze (BRZE) and e.l.f. Beauty (ELF). Company Calendar Last Earnings11/08/2021Today11/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drug stores & proprietary stores Sub-IndustryN/A Current SymbolNASDAQ:MDVL CUSIPN/A CIK1402479 Webwww.medavail.com Phone(905) 812-0023Fax973-348-5707Employees279Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($28.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-47,620,000.00 Net Margins-192.97% Pretax MarginN/A Return on Equity-218.10% Return on Assets-103.45% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$43.33 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$13.01 per share Price / BookN/AMiscellaneous Outstanding Shares1,614,000Free Float1,590,000Market Cap$2.91 million OptionableNo Data Beta0.76 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report This page (NASDAQ:MDVL) was last updated on 11/25/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MedAvail Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MedAvail With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
